Presentation is loading. Please wait.

Presentation is loading. Please wait.

F. Ceccherini-Silberstein, V. Cento, V. Calvez, C.-F. Perno 

Similar presentations


Presentation on theme: "F. Ceccherini-Silberstein, V. Cento, V. Calvez, C.-F. Perno "— Presentation transcript:

1 The use of human immunodeficiency virus resistance tests in clinical practice 
F. Ceccherini-Silberstein, V. Cento, V. Calvez, C.-F. Perno  Clinical Microbiology and Infection  Volume 16, Issue 10, Pages (October 2010) DOI: /j x Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

2 FIG. 1 Histograms representing the number of genotypic resistance tests (GRTs) performed in our virology laboratory in Rome in the last 10 years. (a) Number of pol (protease (PR)/reverse transcriptase (RT)) GRTs performed over the years. (b) Number of GRTs of PR/RT, GP41, integrase and V3-Gp120 performed over the years. The numbers given at the top of the ‘overall’ bar indicate the total number of GRTs per year. Clinical Microbiology and Infection  , DOI: ( /j x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

3 FIG. 2 Number of genotypic resistance tests (GRTs) performed at first treatment failure in relation to viral load and year of treatment start. Clinical Microbiology and Infection  , DOI: ( /j x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions


Download ppt "F. Ceccherini-Silberstein, V. Cento, V. Calvez, C.-F. Perno "

Similar presentations


Ads by Google